January 13, 2020
Concerto HealthAI, the market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today it has raised $150 million in aggregate Series B financing. The round of financing was led by Declaration Partners with participation from Maverick Ventures, Alliance Bernstein, and SymphonyAI.
Get access to detailed funding analysis, investor insights, company intelligence, and much more
Round size percentiles, market activity, sector trends
Growth stage analysis, funding history, investor quality
Export data, save to watchlist, share analysis
Join thousands of investors, founders, and analysts who rely on Seedtable's intelligence platform